secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2023-12-06T23:59:59+00:00
Accession:  0001104659-23-123841
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio prices $4.5M public offering of common stock and warrants at $2.00/unit
----------------------------------------------------------------------------

- Gross proceeds $4.5M; net proceeds ~$3.6M after fees and expenses.
- Offering comprises 2.25M shares (or pre-funded warrants) plus Series C (2-year) and Series D (5-year) warrants.
- Series C and D warrants each exercisable for one share at $2.00, immediately exercisable.
- Closing expected Dec 7, 2023; proceeds for working capital, R&D, and severance payments.
- A.G.P./Alliance Global Partners lead placement agent; Brookline Capital Markets co-placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000110465923123841/0001104659-23-123841-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000110465923123841/tm2332212d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-123841

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer